Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,082 | 2,810 | 2,470 | 2,168 | 2,715 |
| Operating Income | -3,082 | -2,810 | -2,470 | -2,168 | -2,715 |
| Other Income | 72 | 83 | 65 | 86 | 102 |
| Pre-tax Income | -3,010 | -2,726 | -2,405 | -2,082 | -2,613 |
| Net Income Continuous | -3,010 | -2,726 | -2,405 | -2,082 | -2,613 |
| Net Income | $-3,010 | $-2,726 | $-2,405 | $-2,082 | $-2,613 |
| EPS Basic Total Ops | -1.01 | -1.11 | -1.47 | -1.54 | -1.94 |
| EPS Basic Continuous Ops | -1.01 | -1.11 | -1.47 | -1.54 | -1.94 |
| EPS Diluted Total Ops | -1.01 | -1.11 | -1.47 | -1.54 | -1.94 |
| EPS Diluted Continuous Ops | -1.01 | -1.11 | -1.47 | -1.54 | -1.94 |
| EPS Diluted Before Non-Recurring Items | -1.01 | -1.11 | -0.24 | N/A | N/A |
| EBITDA(a) | $-3,082 | $-2,810 | $-2,469 | $-2,168 | $-2,715 |